News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medicilon-MPI Preclinical Research (Shanghai) LLC Introduces Board of Directors


4/8/2008 9:15:15 AM

MATTAWAN, Mich.--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research Shanghai has announced its newly formed Board of Directors, which has equal representation from the two parent companies. The four directors include executives William U. Parfet and William Harrison from MPI Research, and Drs. Chun-Lin Chen and Jintao Zhang from Medicilon.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES